BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2103508)

  • 1. The myc gene family proteins and their role in transformation and differentiation.
    Ingvarsson S
    Semin Cancer Biol; 1990 Dec; 1(6):359-69. PubMed ID: 2103508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-MYC: evidence for multiple regulatory functions.
    Penn LJ; Laufer EM; Land H
    Semin Cancer Biol; 1990 Feb; 1(1):69-80. PubMed ID: 2133113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells.
    Ingvarsson S; Sundaresan S; Jin P; Francke U; Asker C; Sümegi J; Klein G; Sejersen T
    Oncogene; 1988 Dec; 3(6):679-85. PubMed ID: 2577870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The v-myc oncogene.
    Lee CM; Reddy EP
    Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S; Mascarenhas NT; Taparowsky EJ
    Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of the activities and properties of c-myc required to inhibit cell differentiation.
    Freytag SO; Dang CV; Lee WM
    Cell Growth Differ; 1990 Jul; 1(7):339-43. PubMed ID: 2278885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
    Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
    Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation.
    La Rocca SA; Crouch DH; Gillespie DA
    Oncogene; 1994 Dec; 9(12):3499-508. PubMed ID: 7970710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
    Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the N-terminal domain of the Myc oncoprotein.
    Oster SK; Mao DY; Kennedy J; Penn LZ
    Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes with potential nuclear function: myc, myb and fos.
    Eisenman RN; Thompson CB
    Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of Nmi, a novel partner of Myc proteins.
    Bao J; Zervos AS
    Oncogene; 1996 May; 12(10):2171-6. PubMed ID: 8668343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of myc amplification and overexpression in cell growth, differentiation and death.
    Koskinen PJ; Alitalo K
    Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
    Quéva C; Hurlin PJ; Foley KP; Eisenman RN
    Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation and transformation by Myc proteins.
    Adhikary S; Eilers M
    Nat Rev Mol Cell Biol; 2005 Aug; 6(8):635-45. PubMed ID: 16064138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.